Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Minsheng Healthcare is a China-based healthcare and consumer health company focused on vitamin and mineral over-the-counter medicines, health foods, and probiotic products. It is a subsidiary of the broader Minsheng Pharma Holdings group and traces its heritage to the historic Minsheng pharmaceutical franchise founded in 1926. The company’s flagship product is 21 SUPER-VITA multivitamin with multimineral tablets, and it has expanded its portfolio into probiotics and broader wellness products. Minsheng Healthcare integrates R&D, manufacturing, and commercialization, with a smart factory and GMP-based quality systems supporting production. It listed on China’s ChiNext market in September 2023 and is primarily a commercial-stage health products business rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Minsheng.